These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27042415)

  • 1. Effects of gliclazide add on metformin on serum omentin-1 levels in patients with type 2 diabetes mellitus.
    Al-Gareeb AI; Alrubai HF; Suliaman SM
    Indian J Endocrinol Metab; 2016; 20(2):195-8. PubMed ID: 27042415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Gliclazide or Gliclazide plus Metformin Combination on Glycemic Control in Patients with T2DM in India: A Real-World, Retrospective, Longitudinal, Observational Study from Electronic Medical Records.
    Polavarapu NK; Kale R; Sethi B; Sahay RK; Phadke U; Ramakrishnan S; Mane A; Mehta S; Shah S
    Drugs Real World Outcomes; 2020 Dec; 7(4):271-279. PubMed ID: 32648242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of effects of gliclazide, metformin and pioglitazone monotherapies on glycemic control and cardiovascular risk factors in patients with newly diagnosed uncontrolled type 2 diabetes mellitus.
    Erem C; Ozbas HM; Nuhoglu I; Deger O; Civan N; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2014 May; 122(5):295-302. PubMed ID: 24710641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Blood Glucose Regulation in Omentin-1 Levels among Diabetic Patients.
    Arman Y; Kirna K; Ugurlukisi B; Kutlu O; Dikker O; Cil EO; Akarsu M; Ozcan M; Yuruyen G; Demir P; Altun O; Ozsenel EB; Erdem MG; Sandikci R; Tukek T
    Exp Clin Endocrinol Diabetes; 2017 Apr; 125(4):262-266. PubMed ID: 28073124
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of metformin plus gliclazide compared with metformin alone on circulating endothelial progenitor cell in type 2 diabetic patients.
    Chen LL; Liao YF; Zeng TS; Yu F; Li HQ; Feng Y
    Endocrine; 2010 Oct; 38(2):266-75. PubMed ID: 20972736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study.
    Matthews DR; Charbonnel BH; Hanefeld M; Brunetti P; Schernthaner G
    Diabetes Metab Res Rev; 2005; 21(2):167-74. PubMed ID: 15386821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetes.
    Betteridge DJ; Vergès B
    Diabetologia; 2005 Dec; 48(12):2477-81. PubMed ID: 16283239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of metformin and pioglitazone on omentin and leptin concentrations in patients with newly diagnosed diabetes: a randomized clinical trial.
    Esteghamati A; Noshad S; Rabizadeh S; Ghavami M; Zandieh A; Nakhjavani M
    Regul Pept; 2013 Mar; 182():1-6. PubMed ID: 23328000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes.
    Pan HY; Guo L; Li Q
    Diabetes Res Clin Pract; 2010 Apr; 88(1):29-33. PubMed ID: 20129687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidiabetic effect of mangiferin in combination with oral hypoglycemic agents metformin and gliclazide.
    Sekar V; Mani S; Malarvizhi R; Nithya P; Vasanthi HR
    Phytomedicine; 2019 Jun; 59():152901. PubMed ID: 30981189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysing adipokine Omentin-1 in periodontal disease and type-2 diabetes mellitus: An interventional comparative study.
    Dooxa Nongrum A; Guru SR; K J N; Aghanashini S
    J Oral Biol Craniofac Res; 2022; 12(2):273-278. PubMed ID: 35345627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of effect of pioglitazone with metformin or sulfonylurea (monotherapy and combination therapy) on postload glycemia and composite insulin sensitivity index during an oral glucose tolerance test in patients with type 2 diabetes.
    Ceriello A; Johns D; Widel M; Eckland DJ; Gilmore KJ; Tan MH
    Diabetes Care; 2005 Feb; 28(2):266-72. PubMed ID: 15677777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative three-month study of the efficacies of metformin and gliclazide in the treatment of NIDD.
    Noury J; Nandeuil A
    Diabete Metab; 1991 May; 17(1 Pt 2):209-12. PubMed ID: 1936478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologic Surveillance of Glycemic Response to a Scored, Breakable, Extended Release, Fixed Dose Combination of Gliclazide and Metformin in Persons with Type 2 Diabetes.
    Kalra S; Das AK
    J Assoc Physicians India; 2017 Jun; 65(6):38-41. PubMed ID: 28782312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on plasma omentin-1 levels in patients with type 2 diabetes mellitus.
    Yan P; Li L; Yang M; Liu D; Liu H; Boden G; Yang G
    Diabetes Res Clin Pract; 2011 Jun; 92(3):368-74. PubMed ID: 21458097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of metformin, gliclazide MR and rosiglitazone in monotherapy and in combination for type 2 diabetes.
    Vilar L; Canadas V; Arruda MJ; Arahata C; Agra R; Pontes L; Montenegro L; Vilar CF; Silva LM; Albuquerque JL; Gusmão A
    Arq Bras Endocrinol Metabol; 2010 Mar; 54(3):311-8. PubMed ID: 20520962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum omentin-1 levels in type 2 diabetic obese women in relation to glycemic control, insulin resistance and metabolic parameters.
    Elsaid NH; Sadik NA; Ahmed NR; Fayez SE; Mohammed NAE
    J Clin Transl Endocrinol; 2018 Sep; 13():14-19. PubMed ID: 30023310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the micro- and macro-vascular effects of glimepiride and gliclazide in metformin-treated patients with Type 2 diabetes: a double-blind, crossover study.
    Dhindsa P; Davis KR; Donnelly R
    Br J Clin Pharmacol; 2003 Jun; 55(6):616-9. PubMed ID: 12814458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of omentin 1 and IL-6 in type 2 diabetes mellitus patients with diabetic nephropathy.
    Senthilkumar GP; Anithalekshmi MS; Yasir M; Parameswaran S; Packirisamy RM; Bobby Z
    Diabetes Metab Syndr; 2018; 12(1):23-26. PubMed ID: 28864059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.